The purpose of this study is to assess the affect of multiple health education interventions for statins medication Persistence and clinical prognosis of ischemic stroke patients at 3, 6 and 12 months.
The study is a prospective, multicenter, hospital-based study on secondary prevention for patients with ischemic cerebrovascular diseases between May 2014 and June 2015. Physicians from 24 hospitals in Beijing underwent a standard secondary prevention training of ischemic cerebrovascular diseases by professional training, instruction manuals, stratification management software. In order to improve the persistence of taking preventive secondary medicine, IS patients from these 24 hospitals received healthy education through manuals and Digital Video Disc about health education during hospitalization and acquired secondary preventive knowledge of ischemic cerebrovascular diseases through regular health education messages during 6 months after discharge. Patients with IS from other 6 hospitals were used as a control, and no such intervention was given to them. Telephone follow-up was performed at 3 months, 6 months, and 1 year after the onset of cerebral infarction, during which the use of antiplatelet and statins drugs and recurrence of IS were recorded. Patients who took antiplatelet drugs or statins at three follow-ups were regarded as persistent antiplatelet drugs or statins taking within one year after the onset of the disease. The main prognostic indicator was the recurrence of IS and persistence of statins medication within 1 year, and the main purpose was to explore the impact of persistent statins use on IS recurrence.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
3,111
Beijing Tian Tan Hospital, Capital Medical University
Beijing, China
Proportion of patients who continued taking statins drugs at three months after stroke onset.
Statins Medication persistence at 3 months. Patients who took statins at three months follow-up were regarded as persistent during three months.
Time frame: 3 months after stroke onset
Proportion of patients who continued taking statins drugs at six months after stroke onset.
Statins Medication persistence at 6 months.Patients who took statins at six months follow-up were regarded as persistent at six months.
Time frame: 6 months after stroke onset
Proportion of patients who continued taking statins drugs at 12 months after stroke onset.
Statins Medication persistence at 12 months.Patients who took statins at twelve months follow-up were regarded as persistent at twelve months.
Time frame: 12 months after stroke onset
Proportion of patients who continued taking statins drugs in 1 year after stroke onset.
Statins Medication persistence in 1 year: Patients who took statins at 3, 6 and 12 months follow-up were regarded as persistent during one year after stroke onset.
Time frame: 1 year after stroke onset
Recurrence of ischemic stroke in three months after stroke onset
Recurrence of ischemic stroke was defined as a new focal neurological deficit of vascular origin lasting \>24 hours and without hemorrhage on computed tomography or MRI of the brain.
Time frame: 3 months after stroke onset
Recurrence of ischemic stroke in six months after stroke onset
Recurrence of ischemic stroke was defined as a new focal neurological deficit of vascular origin lasting \>24 hours and without hemorrhage on computed tomography or MRI of the brain.
Time frame: 6 months after stroke onset
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Recurrence of ischemic stroke in 12 months after stroke onset
Recurrence of ischemic stroke was defined as a new focal neurological deficit of vascular origin lasting \>24 hours and without hemorrhage on computed tomography or MRI of the brain.
Time frame: 12 months after stroke onset
Percentage of patients with 3-month poor clinical prognosis (including Death or Nonfatal myocardial infarction or Nonfatal hemorrhagic stroke or Severe disabilities) as a cluster and evaluated individually
Death included Vascular death and non-vascular death; Severe disabilities was defined as modified Rankin Scale ≥4
Time frame: 3 months after stroke onset
Percentage of patients with 6-month poor clinical prognosis (including Death or Nonfatal myocardial infarction or Nonfatal hemorrhagic stroke or Severe disabilities) as a cluster and evaluated individually
Death included Vascular death and non-vascular death; Severe disabilities was defined as modified Rankin Scale ≥4
Time frame: 6 months after stroke onset
Percentage of patients with 12-month poor clinical prognosis (including Death or Nonfatal myocardial infarction or Nonfatal hemorrhagic stroke or Severe disabilities) as a cluster and evaluated individually
Death included Vascular death and non-vascular death; Severe disabilities was defined as modified Rankin Scale ≥4
Time frame: 12 months after stroke onset